8-K: PHIO Pharmaceuticals Announces 2025 Annual Meeting Date and Revised Stockholder Proposal Deadlines

PHIO Pharmaceuticals Corp. has set September 11, 2025, as the date for its 2025 Annual Meeting of Stockholders, necessitating revised deadlines for stockholder proposals and director nominations due to the change from the prior year's anniversary.

Summary

• The 2025 Annual Meeting of Stockholders for PHIO Pharmaceuticals Corp. is scheduled for September 11, 2025.
• Stockholders of record at the close of business on July 18, 2025, will be eligible to receive notice and vote at the 2025 Annual Meeting.
• The scheduled date of the 2025 Annual Meeting has been changed by more than 30 days from the anniversary of the 2024 Annual Meeting.
• The deadline for stockholder proposals submitted pursuant to Rule 14a-8 for inclusion in the Company's proxy materials is July 17, 2025, by 5:00 p.m. Eastern Time.
• The deadline for director nominations or other stockholder proposals not seeking inclusion in proxy materials (pursuant to Rule 14a-8) is also July 17, 2025.
• The Company expects to begin printing and mailing its proxy materials for the 2025 Annual Meeting on or about July 30, 2025.
• Stockholders intending to solicit proxies in support of director nominees other than the Company's nominees must provide notice required by Rule 14a-19 by July 17, 2025.
• All stockholder proposals and director nominations must comply with applicable SEC rules and the Company's Fifth Amended and Restated Bylaws.

Sentiment

Score: 5

Explanation: The document is a neutral, administrative update regarding the scheduling of the annual meeting and associated deadlines, with no direct positive or negative financial implications.

Negatives

• The 2025 Annual Meeting date has been changed by more than 30 days from the anniversary of the 2024 Annual Meeting, which required the revision of previously disclosed deadlines for stockholder proposals and nominations.

Management Comments

• The report was signed by Robert J. Bitterman, President & Chief Executive Officer of PHIO Pharmaceuticals Corp.

Corporate Governance

Stakeholder Impact

• Shareholders: Directly impacted by the new record date for voting eligibility and the revised deadlines for submitting proposals and director nominations.

Next Steps

• The Company will set forth the time, location, and other meeting details for the 2025 Annual Meeting in its definitive proxy statement.
• The Company will file its definitive proxy statement for the 2025 Annual Meeting with the U.S. Securities and Exchange Commission prior to the meeting.
• The Company expects to begin printing and mailing its proxy materials on or about July 30, 2025.
• The 2025 Annual Meeting of Stockholders will be held on September 11, 2025.

Key Dates

Keywords

PHIO Pharmaceuticals, Annual Meeting, Stockholder Meeting, Proxy Statement, Corporate Governance, SEC Filing, Rule 14a-8, Rule 14a-19, Stockholder Proposals, Director Nominations